Gene · 1237
Papers2,300
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,300
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Timosaponin AIII enhances CAR-T cell potency and prevents relapse through impairing CAR-Tregs. | Nat Commun | 2026 | 41916982 | PubTator, text mining | PubMed |
| [Research Progress on Glycolytic Reprogramming and Lactylation Crosstalk in Tumors]. | Zhongguo Fei Ai Za Zhi | 2026 | 41916915 | PubTator, text mining | PubMed |
| Key molecules and functional subsets of regulatory T cells in maternal-fetal immune tolerance: Recent advances. | J Reprod Immunol | 2026 | 41903503 | PubTator, text mining | PubMed |
| How to Employ Trained Immunity and Trained Immunity-Based Vaccines to Inhibit Allergic Inflammation. | Vaccines (Basel) | 2026 | 41893804 | PubTator, text mining | PubMed |
| Dynamic changes of the immune microenvironment in ovarian cancer following neoadjuvant chemotherapy. | Cell Death Discov | 2026 | 41872134 | PubTator, text mining | PubMed |
| KLRG1 defines a distinct tumor-infiltrating granzyme K+ CD8 + T cell population. | J Cancer Res Clin Oncol | 2026 | 41857425 | PubTator, text mining | PubMed |
| Tumor Cells as Architects of Immune Refractoriness: Dismantling Intrinsic Programs of Tumor Cells for Clinical Translation. | Immune Netw | 2026 | 41800027 | PubTator, text mining | PubMed |
| Regulatory T Cell Heterogeneity in the Steady State and Tumor. | Immune Netw | 2026 | 41800022 | PubTator, text mining | PubMed |
| Mapping the TNFR2-targeting antibody patent landscape: Insights from macro trends to structural signatures. | Hum Vaccin Immunother | 2026 | 41797544 | PubTator, text mining | PubMed |
| CCR8 orchestrates an immunosuppressive niche in the liver to promote Echinococcus multilocularis infection. | PLoS Negl Trop Dis | 2026 | 41790619 | PubTator, text mining | PubMed |
| Taming autoimmune thyroiditis: cellular immunomodulation through MSCs, Tregs, and tolDCs. | Front Immunol | 2026 | 41789058 | PubTator, text mining | PubMed |
| Targeting molecular pathways in neuropathic cancer pain: from mechanisms to novel therapeutics. | iScience | 2026 | 41782818 | PubTator, text mining | PubMed |
| The Role of Rarely Studied Chemokines in Tumor Progression in Multiple Myeloma (MM). | Cancers (Basel) | 2026 | 41749925 | PubTator, text mining | PubMed |
| Novel Blood-Based Extracellular Vesicle-Derived Biomarkers in Small Cell Lung Cancer Identified via Proximity Extension Assay. | Cancers (Basel) | 2026 | 41749831 | PubTator, text mining | PubMed |
| Specific depletion of TIGIThigh CD226- clonally expanded intratumoral Tregs defines safe and effective TIGIT targeting. | J Immunother Cancer | 2026 | 41735000 | PubTator, text mining | PubMed |
| Inflammatory Mediators of Alzheimer's Disease Characterized in a Mouse Model (APP/PS1). | NeuroSci | 2026 | 41718152 | PubTator, text mining | PubMed |
| CCR-CCL axes as key upstream influencers of pancreatic ductal adenocarcinoma: CCR2-CCL2, CCR5-CCL5, CCR4-CCL17/22, CCR6-CCL20, CCR7-CCL19/21. | Front Immunol | 2026 | 41694374 | PubTator, text mining | PubMed |
| Bioengineering of extracellular vesicles with scaffold proteins for drug delivery. | J Nanobiotechnology | 2026 | 41680844 | PubTator, text mining | PubMed |
| T Cell Exhaustion in Hepatocellular Carcinoma: A Substantial Barrier in Immunotherapy. | J Cell Mol Med | 2026 | 41645702 | PubTator, text mining | PubMed |
| Comprehensive analysis of COLGALT1 in tumor microenvironment regulation and prognosis of clear cell renal cell carcinoma. | Clin Exp Med | 2026 | 41627587 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/papers?page=2